
|Articles|July 1, 2002
What does the future hold?
Author(s)Julia Talsma
Researchers presented new strategies for tack-ling numerous retinal diseases that can have devastating effects on vision in a symposium entitled "New Vessels, New Medicines, New Ideas in Retina." Great progress has been made and con-tinues to be made in this subspecialty, noted Harry W. Flynn Jr., MD, organizer of the 2001 American Academy of Ophthalmology symposium.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Opus Genetics launches phase 1/2 MERTK gene therapy trial
3
FDA approves NDA labeling supplement allowing re-administration of iDose TR
4
FDA Type C meeting supports phase 2b/3 pathway for urcosimod in neuropathic corneal pain
5



























